Today's Date
Imatinib in New-onset T1D
(
GleeT1D
)
ITN Protocol #:
ITN825AI
Branded Name:
GleeT1D
Treatment Protocol #:
Therapeutic Area:
Type 1 Diabetes
Current Status:
Complete
Summary:
Safety and Efficacy of Imatinib for Preserving B-cell Function in New-onset Type 1 Diabetes Mellitus
Clinical Operations Manager
ITN Biostat
Study Personnel:
